Yabao Pharmaceutical Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines. | ![]() Taiho Pharmaceutical Taiho Pharmaceutical (大鵬薬品) is a company that researches, manufactures, and markets medicines, food supplements, and medical devices. | ![]() Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | ||
Founding Date | Founding Date 1995 | Founding Date 1978 | Founding Date 1963 | Founding Date 2012 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Lianyungang Shi, CN HQ | Locations Yuncheng Shi, CN HQ Beijing, CN Yuncheng, CN Yuncheng Shi, CN | Locations Shanghai, CN HQ | |
Employees | Employees 9,099 | Employees 4,142 | Employees 2,1591% decrease | Employees 2,5681% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥10.1b (FY, 2023) | Revenue (est.) ¥2.8b (FY, 2023) | Revenue (est.) ¥139.4b (FY, 2022) | Revenue (est.) ¥1.5b (FY, 2023) |
Cost of goods | Cost of goods ¥664.5m (FY, 2023) | Cost of goods ¥1.2b (FY, 2023) | Cost of goods N/A | Cost of goods ¥541m (FY, 2023) |
Gross profit | Gross profit ¥9.5b (FY, 2023) | Gross profit ¥1.6b (FY, 2023) | Gross profit N/A | Gross profit ¥941.9m (FY, 2023) |
Net income | Net income ¥3.3b (FY, 2023) | Net income ¥179.9m (FY, 2023) | Net income ¥5.1b (FY, 2022) | Net income (¥2.5b) (FY, 2023) |
Operating ⚠ | ||||
Trademarks | Trademarks N/A | Trademarks 51 (Sep, 2023) | Trademarks 520 (Jun, 2023) | Trademarks N/A |
Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines.
View companyTaiho Pharmaceutical (大鵬薬品) is a company that researches, manufactures, and markets medicines, food supplements, and medical devices.
View companyShanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company